Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia
NICE guidance
Summary (source: NICE)
Reference: HTG469
Type: NICE guidance
Published: 25 April 2018
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia is nice guidance HTG469, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 25 April 2018. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.